Related Experiment Video
Updated: Jul 6, 2026
04:33
Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Insomnia and comorbid psychiatric disorders
1Freiburg University Medical Center, Freiburg, Germany. dieter.riemann@uniklinik-freiburg.de
Sleep Medicine
|April 12, 2008
Summary
Insomnia may predict psychiatric disorders, not just be a symptom. Research shows sleep disturbances, like altered REM sleep, are linked to depression and may be an independent risk factor.
Area of Science:
- Neuroscience
- Psychiatry
- Sleep Medicine
Background:
- Insomnia is increasingly recognized as more than a symptom of psychiatric disorders.
- It may serve as an independent risk factor for developing conditions like depression.
- Depression is associated with specific sleep abnormalities, including REM sleep dysregulation.
Purpose of the Study:
- To explore the complex relationship between sleep disturbances and psychiatric disorders.
- To investigate insomnia as a potential predictor of psychiatric conditions.
- To understand the neurobiological underpinnings of the insomnia-depression link.
Main Methods:
- Review of existing studies on sleep disturbances and psychiatric disorders.
- Analysis of sleep continuity, slow wave sleep, and REM sleep patterns in depressed patients.
- Examination of the role of cholinergic systems in REM sleep regulation and depression risk.
Main Results:
- Depressed patients exhibit disrupted sleep continuity, reduced slow wave sleep, and altered REM sleep (shortened latency, increased density).
- Cholinergic stimulation impacts REM latency, particularly in major depressive disorder.
- Individuals at high risk for depression show heightened sensitivity to cholinergic agents.
Conclusions:
- Insomnia is a significant independent risk factor for depression and other psychiatric disorders.
- The interplay between sleep-wake cycles and neurochemical systems is crucial in psychiatric pathophysiology.
- Further research into these pathophysiological links can inform better treatment strategies.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Related Concept Videos
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.